Quantcast

Latest lidocaine Stories

2010-08-24 07:00:00

FRANKLIN, Mass., Aug. 24 /PRNewswire-FirstCall/ -- Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE), a company developing its needle-free Symphony(TM) tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude(TM) SkinPrep System for transdermal drug delivery, today announced the completion of a clinical study of Prelude. This clinical study was designed to evaluate the ability of Prelude to ablate the skin prior to the application of OTC...

2010-05-17 16:31:00

FRANKLIN, Mass., May 17 /PRNewswire-FirstCall/ -- Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE), a company developing its needle-free Symphony(TM) tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and its Prelude(TM) SkinPrep System for transdermal drug delivery, today announced financial results for the period ended March 31, 2010. Recent Corporate Highlights: In April, Echo Therapeutics and Ferndale Pharma Group initiated a...

2010-04-27 07:06:00

FRANKLIN, Mass., April 27 /PRNewswire-FirstCall/ -- Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE), a company developing its needle-free Symphony(TM) tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and its Prelude(TM) SkinPrep System for transdermal drug delivery, in collaboration with its strategic partner, Ferndale Pharma Group, Inc., announced today that the first patients were enrolled in a clinical study of its Prelude SkinPrep...

2010-03-23 11:15:00

Imagine if your fear of spiders, heights or flying could be cured with a simple injection. Research published in BioMed Central's open access journal, Behavioral and Brain Functions suggests that one day this could be a reality. The cerebellum, an area of the brain thought to be involved with the development of our fears, was studied in goldfish by researchers at the University of Hiroshima in Japan. Using classical conditioning, Masayuki Yoshida and Ruriko Hirano taught their fish to become...

2010-03-22 07:00:00

WALTHAM, Mass., March 22 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a novel formulation of Pfizer's Neurontin that is dosed once a day would earn a 50 percent patient share in the treatment of postherpetic neuralgia, according to surveyed U.S. neurologists. In Europe, such an agent would earn a patient share of 40 percent, according to surveyed European neurologists. Such a drug would...

2010-03-16 08:00:00

IRVINE, Calif., March 16 /PRNewswire-FirstCall/ -- Allergan, Inc. (NYSE: AGN) has announced the national launch of the JuvEderm® "Switch Up" campaign, spearheaded by television personality Dayna Devon who will share ways to maintain a fresh appearance as women approach milestone birthdays. Devon, who turns 40 this month and is a mother of two young children, has developed an easy strategy for women to switch up their current routines and take advantage of effective...

2010-02-09 07:35:00

FRANKLIN, Mass., Feb. 9 /PRNewswire-FirstCall/ -- Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE), a company developing the needle-free Symphony(TM) tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude(TM) SkinPrep System for transdermal drug delivery, announced today that Patrick T. Mooney, M.D., the Company's Chairman and CEO, will be interviewed on "Steve Crowley's American Scene National Radio" on Tuesday, February 9, 2010...

2010-02-01 18:01:14

Surprise finding may have implications for labor anesthesia, orthopedics and more One of the holy grails of local anesthesia is the ability to achieve a long-lasting nerve block that eliminates pain sensation while not affecting motor function. Now, researchers at Children's Hospital Boston have discovered an anesthetic approach that seems to do just that. If it proves to work in humans as well as it did in rats, it could be useful in a variety of medical applications, providing, for example,...

2010-01-19 11:53:00

In the news release, Watson Confirms Filing of FDA Application for Generic Lidoderm(R), issued Jan. 19 by Watson Pharmaceuticals, Inc. over PR Newswire, we are advised by the company that the first paragraph, second and third sentences should read "lidocaine topical patch 5%" rather than "lidocaine topical patch 8%" as originally issued inadvertently. The complete, corrected release follows: Watson Confirms Filing of FDA Application for Generic Lidoderm(R) MORRISTOWN, N.J., Jan. 19...

2010-01-11 07:00:00

FRANKLIN, Mass., Jan 11 /PRNewswire-FirstCall/ -- Echo Therapeutics, Inc. (OTC Bulletin Board : ECTE), a company developing the needle-free Symphony(TM) tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude(TM) SkinPrep System for transdermal drug delivery, announced today that the Company has completed the product development work for its Prelude SkinPrep System and now has the commercially ready product to be used in final...


Word of the Day
barratry
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.
Related